Cure My Disease

Don't miss your cure!

 Log in / Sign up

10,000 DNA samples could reveal hidden genetic triggers for leukemia and lymphoma

NCT ID NCT07714044

Not yet recruiting Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study aims to enroll 10,000 adults across the United States to help identify genetic variants linked to blood cancers such as leukemia, lymphoma, and myeloma. Participants complete online health surveys and provide a saliva sample by mail. Researchers will analyze the DNA to find both new and known genetic risk factors for these cancers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify new genetic risk factors for blood cancers, potentially leading to better screening or prevention strategies.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and finding meaningful genetic links is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm leukemia lymphoma plasma cell myeloma plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD CANCER BLOOD CANCERS HEMATOLOGIC CANCER HEMATOLOGIC MALIGNANCIES HEMATOLOGIC NEOPLASM HEMATOLOGIC TUMORS LEUKEMIA LYMPHOMA MYELOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rutgers University

    Piscataway, New Jersey, 08854, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.